Transdermal Contraception Patch: EU Cycle Control Study Versus EVRA.
Phase of Trial: Phase III
Latest Information Update: 13 Sep 2016
At a glance
- Drugs Ethinylestradiol/gestodene (Primary) ; Ethinylestradiol/norelgestromin
- Indications Pregnancy
- Focus Registrational; Therapeutic Use
- Sponsors Bayer
- 19 Nov 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 24 Jun 2010 Actual patient number (391) added as reported by ClinicalTrials.gov.
- 03 Feb 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.